Doctor profile · Federal record
Dr. Zachary Castor, PA-C
Physician Assistant · Wichita, KS
- NPI 1760882112
- Accepts Medicare
- 12 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
3715 N Oliver St
Wichita, KS 67220
(316) 942-4519
fax (316) 942-4655 - Additional location
-
929 N Saint Francis St
Wichita, KS 672143821
(316) 268-5000
Credentials & registration
- NPI registered
- September 2014 — 12 yrs on file
- Profile last updated
- June 25, 2019
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Kansas #15-01727
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760882112. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,843
Distinct HCPCS
10
Medicare allowed
$433,433
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 5,400 | 12 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 1,980 | 13 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 422 | 385 | $71 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 243 | 218 | $101 | |
51798 |
Ultrasound measurement of bladder capacity after voiding | 152 | 139 | $10 | |
J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg | 135 | 33 | $172 | |
81001 |
Manual urinalysis test with examination using microscope, automated | 116 | 110 | $3 | |
81003 |
Automated urinalysis test | 58 | 58 | $2 | |
96402 |
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | 35 | $26 | |
36415 |
Insertion of needle into vein for collection of blood sample | 41 | 41 | $8 |
In context: peer comparison
Among 95 peers in this city , average services per provider: 189. This provider delivers 47× the peer median.Open Payments
Industry payments received
All-time total
$409
Transactions
21
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 3 | $52.55 | |
| Sumitomo Pharma America, Inc. | 3 | $51.90 | |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $50.07 | |
| Dendreon Pharmaceuticals LLC | 2 | $49.63 | |
| Merck Sharp & Dohme LLC | 3 | $46.40 | |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30.94 | |
| Axonics, Inc. | 1 | $26.09 | |
| Alnylam Pharmaceuticals Inc. | 1 | $21.21 | |
| Teleflex LLC | 1 | $20.72 | |
| Boston Scientific Corporation | 1 | $16.58 | |
| UROGEN PHARMA, INC. | 1 | $15.15 | |
| Astellas Pharma US Inc | 1 | $14.59 | |
| PFIZER INC. | 1 | $13.32 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
945
Patients
264
Total drug cost
$78,785
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tamsulosin Hcl | Generic | 242 | 60 | $3,259 |
| Potassium Citrate Er (Potassium Citrate) | Brand | 106 | 35 | $11,910 |
| Allopurinol | Generic | 80 | 18 | $735 |
| Hydrochlorothiazide | Generic | 74 | 20 | $637 |
| Cephalexin | Generic | 71 | 51 | $654 |
| Alfuzosin Hcl Er (Alfuzosin Hcl) | Brand | 51 | 0 | $878 |
| Chlorthalidone | Generic | 51 | 23 | $585 |
| Gemtesa (Vibegron) | Brand | 39 | 0 | $30,888 |
| Solifenacin Succinate | Generic | 38 | 0 | $2,219 |
| Myrbetriq (Mirabegron) | Brand | 37 | 0 | $23,739 |
Hospital affiliations
Frequently asked questions
What is Dr. Zachary Castor's medical specialty?
Dr. Zachary Castor practices Physician Assistant in Wichita, KS.
Where does Dr. Zachary Castor practice?
Dr. Zachary Castor practices at 3715 N Oliver St, Wichita, KS 67220. Office phone: 3169424519.
What is Dr. Zachary Castor's NPI?
Dr. Zachary Castor's National Provider Identifier (NPI) is 1760882112, issued by NPPES.
Does Dr. Zachary Castor accept Medicare assignment?
Yes. Dr. Zachary Castor accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Zachary Castor commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.